Human therapeutics by targeting proteins
Learn more about how Team Parker are designing new antibiotics using computational and experimental methods to develop treatments for diseases.
The problem
Antimicrobial resistance is an urgent global health concern that threatens to render current antibiotics ineffective.
Our solution
We use computational modeling and experimental approaches to study drug-target enzymes and design new potential antibiotics.
The impact
Our work leads to the development of new treatments for diseases, novel antibiotics, vaccine components (such as those for SARS-CoV-2), and more.